{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T17:37:42Z","timestamp":1769017062931,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gen Intern Med"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1111\/j.1525-1497.2004.30419.x","type":"journal-article","created":{"date-parts":[[2004,7,8]],"date-time":"2004-07-08T21:15:56Z","timestamp":1089321356000},"page":"879-886","source":"Crossref","is-referenced-by-count":31,"title":["Should aspirin be continued in patients started on warfarin?"],"prefix":"10.1007","volume":"19","author":[{"given":"Robin J.","family":"Larson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliott S.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1908879_CR1","doi-asserted-by":"crossref","unstructured":"Steering Committee of the Physicians\u2019 Health Study Research Group final report on the aspirin component of the ongoing Physicians\u2019 Health Study. N Engl J Med. 1989;321:129\u201335.","DOI":"10.1056\/NEJM198907203210301"},{"key":"1908879_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","volume":"308","author":"Antiplatelet Trialists\u2019 Collaboration","year":"1994","unstructured":"Antiplatelet Trialists\u2019 Collaboration. Collaborative overview of randomized trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81\u2013106.","journal-title":"BMJ"},{"key":"1908879_CR3","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/0140-6736(92)92619-Q","volume":"340","author":"S Juul-Moller","year":"1992","unstructured":"Juul-Moller S, Edvardsson N, Jahnmatz B, et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet. 1992;340:1421\u20135.","journal-title":"Lancet"},{"key":"1908879_CR4","unstructured":"National Center for Health Statistics. Center for Disease Control and Prevention. Available at: http:\/\/www.cdc.gov\/nchs\/. Accessed 2002."},{"key":"1908879_CR5","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0149-2918(01)80134-X","volume":"23","author":"AH Abdelhafiz","year":"2001","unstructured":"Abdelhafiz AH. A review of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation. Clin Ther. 2001;23:1628\u201336.","journal-title":"Clin Ther"},{"key":"1908879_CR6","doi-asserted-by":"crossref","unstructured":"Anonymous. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449\u201357.","DOI":"10.1001\/archinte.1994.00420130036007"},{"key":"1908879_CR7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-131-9-199911020-00010","volume":"131","author":"RG Hart","year":"1999","unstructured":"Hart RG, Halperin JL. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann Intern Med. 1999;131:688\u201395.","journal-title":"Ann Intern Med"},{"key":"1908879_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199507063330103","volume":"333","author":"SC Cannegieter","year":"1995","unstructured":"Cannegieter SC, Rosendaal FR, Wintzen AR. Optimal oral anti-coagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995;333:11\u20137.","journal-title":"N Engl J Med"},{"key":"1908879_CR9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","volume":"25","author":"M Heras","year":"1995","unstructured":"Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol. 1995;25:1111\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1908879_CR10","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.93.12.2212","volume":"93","author":"J Hirsh","year":"1996","unstructured":"Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. Circulation. 1996;93:2212\u201345.","journal-title":"Circulation"},{"key":"1908879_CR11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/01.CIR.100.9.1016","volume":"100","author":"TJ Ryan","year":"1999","unstructured":"Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC\/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1999;100:1016\u201330.","journal-title":"Circulation"},{"key":"1908879_CR12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-8703(77)80351-7","volume":"94","author":"J Dale","year":"1977","unstructured":"Dale J, Myhre E, Storstein O, Stormorken H, Efskind L. Prevention of arterial thromboembolism with acetylsalicylic acid. A controlled clinical study in patients with aortic ball valves. Am Heart J. 1977;94:101\u201311.","journal-title":"Am Heart J"},{"key":"1908879_CR13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-5223(19)40105-0","volume":"72","author":"R Altman","year":"1976","unstructured":"Altman R, Boullon F, Rouvier J, Raca R, de la Fuente L, Favaloro RG. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. J Thorac Cardiovasc Surg. 1976;72:127\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1908879_CR14","unstructured":"Review Manager (RevMan). The Cochrane Collaboration. November 4, 2002. Available at: http:\/\/www.cochrane-net.org\/revman\/. Accessed 2002."},{"key":"1908879_CR15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0735-1097(99)00598-7","volume":"35","author":"P Laffort","year":"2000","unstructured":"Laffort P, Roudaut R, Roques X, et al. Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study. J Am Coll Cardiol. 2000;35:739\u201346.","journal-title":"J Am Coll Cardiol"},{"key":"1908879_CR16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","volume":"329","author":"AG Turpie","year":"1993","unstructured":"Turpie AG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med. 1993;329:524\u20139.","journal-title":"N Engl J Med"},{"key":"1908879_CR17","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0002-8703(80)90625-0","volume":"99","author":"J Dale","year":"1980","unstructured":"Dale J, Myhre E, Loew D. Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement. Am Heart J. 1980;99:746\u201352.","journal-title":"Am Heart J"},{"key":"1908879_CR18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0022-5223(97)70264-2","volume":"113","author":"SS Meschengieser","year":"1997","unstructured":"Meschengieser SS, Fondevila CG, Frontroth J, Santarelli MT, Lazzari MA. Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovasc Surg. 1997;113:910\u20136.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1908879_CR19","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1161\/01.CIR.103.25.3069","volume":"103","author":"T Huynh","year":"2001","unstructured":"Huynh T, Theroux P, Bogaty P, Nasmith J, Solymoss S. Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery. Circulation. 2001;103:3069\u201374.","journal-title":"Circulation"},{"key":"1908879_CR20","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","volume":"347","author":"M Hurlen","year":"2002","unstructured":"Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med. 2002;347:969\u201374.","journal-title":"N Engl J Med"},{"key":"1908879_CR21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","volume":"360","author":"RF Es van","year":"2002","unstructured":"van Es RF, Jonker JJ, Verheugt FW, Deckers JW, Grobbee DE. Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 Research G. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet. 2002;360:109\u201313.","journal-title":"Lancet"},{"key":"1908879_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000047711","volume":"12","author":"P Lechat","year":"2001","unstructured":"Lechat P, Lardoux H, Mallet A, et al. Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontane; FFAACS). Cerebrovasc Dis. 2001;12:245\u201352.","journal-title":"Cerebrovasc Dis"},{"issue":"1 suppl","key":"1908879_CR23","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1378\/chest.119.1_suppl.8S","volume":"119","author":"J Hirsh","year":"2001","unstructured":"Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001;119(1 suppl):8S-21S.","journal-title":"Chest"},{"key":"1908879_CR24","doi-asserted-by":"crossref","unstructured":"Anonymous. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation. 1991;84:527\u201339.","DOI":"10.1161\/01.CIR.84.2.527"},{"key":"1908879_CR25","unstructured":"Anonymous. Warfarin versus aspirin for prevention of thromboem-bolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet. 1994;343:687\u201391."},{"key":"1908879_CR26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/hc0502.103329","volume":"105","author":"LD Fiore","year":"2002","unstructured":"Fiore LD, Ezekowitz MD, Brophy MT, et al. Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study. Circulation. 2002;105:557\u201363.","journal-title":"Circulation"},{"key":"1908879_CR27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9149(01)01735-0","volume":"88","author":"CM O\u2019Connor","year":"2001","unstructured":"O\u2019Connor CM, Gattis WA, Hellkamp AS, et al. Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS). Am J Cardiol. 2001;88:541\u20136.","journal-title":"Am J Cardiol"},{"key":"1908879_CR28","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/jama.282.21.2058","volume":"282","author":"SS Anand","year":"1999","unstructured":"Anand SS, Yusuf S. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. JAMA. 1999;282:2058\u201367.","journal-title":"JAMA"},{"key":"1908879_CR29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","volume":"131","author":"RG Hart","year":"1999","unstructured":"Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999;131:492\u2013501.","journal-title":"Ann Intern Med"},{"key":"1908879_CR30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1525-1497.2000.04329.x","volume":"15","author":"JB Segal","year":"2000","unstructured":"Segal JB, McNamara RL, Miller MR, et al. Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. J Gen Intern Med. 2000;15:56\u201367.","journal-title":"J Gen Intern Med"},{"key":"1908879_CR31","doi-asserted-by":"crossref","unstructured":"Anonymous. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council\u2019s General Practice Research Framework. Lancet. 1998;351:233\u201341.","DOI":"10.1016\/S0140-6736(97)11475-1"},{"key":"1908879_CR32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00023210-200115080-00005","volume":"15","author":"M Yasaka","year":"2001","unstructured":"Yasaka M, Yamaguchi T. Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation. CNS Drugs. 2001;15:623\u201331.","journal-title":"CNS Drugs"},{"key":"1908879_CR33","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.288.19.2441","volume":"288","author":"C Walraven van","year":"2002","unstructured":"van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA. 2002;288:2441\u20138.","journal-title":"JAMA"},{"key":"1908879_CR34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000015958","volume":"9","author":"RG Hart","year":"1999","unstructured":"Hart RG, Benavente O, Pearce LA. Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: a meta-analysis and hypothesis. Cerebrovasc Dis. 1999;9:215\u20137.","journal-title":"Cerebrovasc Dis"},{"key":"1908879_CR35","first-page":"717","volume":"14","author":"P Loewen","year":"1998","unstructured":"Loewen P, Sunderji R, Gin K. The efficacy and safety of combination warfarin and ASA therapy: a systematic review of the literature and update of guidelines. Can J Cardiol. 1998;14:717\u201326.","journal-title":"Can J Cardiol"},{"key":"1908879_CR36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","volume":"89","author":"SC Cannegieter","year":"1994","unstructured":"Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994;89:635\u201341.","journal-title":"Circulation"},{"key":"1908879_CR37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0002-8703(95)90365-8","volume":"130","author":"JC Cappelleri","year":"1995","unstructured":"Cappelleri JC, Fiore LD, Brophy MT, Deykin D, Lau J. Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: a meta-analysis. An Heart J. 1995;130:547\u201352.","journal-title":"An Heart J"},{"key":"1908879_CR38","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-0038-1642729","volume":"74","author":"R Altman","year":"1995","unstructured":"Altman R, Rouvier J, Gurfinkel E. Oral anticoagulant treatment with and without aspirin. Thromb Haemost. 1995;74:506\u201310.","journal-title":"Thromb Haemost"},{"key":"1908879_CR39","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(00)01135-9","volume":"37","author":"D Massel","year":"2001","unstructured":"Massel D, Little SH. Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis. J Am Coll Cardiol. 2001;37:569\u201378.","journal-title":"J Am Coll Cardiol"},{"key":"1908879_CR40","unstructured":"2002 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2001."},{"key":"1908879_CR41","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/hc1102.105594","volume":"105","author":"MA Brouwer","year":"2002","unstructured":"Brouwer MA, Verheugt FW. Oral anticoagulation for acute coronary syndromes. Circulation. 2002;105:1270\u20134.","journal-title":"Circulation"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1111\/j.1525-1497.2004.30419.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T17:41:30Z","timestamp":1585849290000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1111\/j.1525-1497.2004.30419.x"}},"subtitle":["A systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["1908879"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1497.2004.30419.x","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}